Cargando…

Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy

Connective tissue turnover plays a prominent role in tumour growth and metastasis. We followed serum levels of seven connective tissue parameters in 37 patients with colorectal cancer metastatic to the liver prior to and during chemotherapy. Serum samples with episodes of tumour control (n=112) show...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanke, B, Wein, A, Martus, P, Riedel, C, Voelker, M, Hahn, E G, Schuppan, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747566/
https://www.ncbi.nlm.nih.gov/pubmed/12698191
http://dx.doi.org/10.1038/sj.bjc.6600832
_version_ 1782172110066548736
author Hanke, B
Wein, A
Martus, P
Riedel, C
Voelker, M
Hahn, E G
Schuppan, D
author_facet Hanke, B
Wein, A
Martus, P
Riedel, C
Voelker, M
Hahn, E G
Schuppan, D
author_sort Hanke, B
collection PubMed
description Connective tissue turnover plays a prominent role in tumour growth and metastasis. We followed serum levels of seven connective tissue parameters in 37 patients with colorectal cancer metastatic to the liver prior to and during chemotherapy. Serum samples with episodes of tumour control (n=112) showed an increase of matrix metalloproteinase-2 (MMP-2) (P⩽0.01) and a decrease of tissue inhibitor of MMPs (TIMP-1) levels (P⩽0.01), while serum samples with episodes of tumour progression displayed the reverse pattern (P⩽0.01 and P⩽0.05, resp.). The ratio of circulating MMP-2/TIMP-1 was also significantly higher in episodes of tumour control vs tumour progression and prior to treatment (P⩽0.0001). We conclude that serum MMP-2 appears to reflect tumour resorption, while serum TIMP-1 may mirror tumour expansion.
format Text
id pubmed-2747566
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27475662009-09-21 Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy Hanke, B Wein, A Martus, P Riedel, C Voelker, M Hahn, E G Schuppan, D Br J Cancer Molecular and Cellular Pathology Connective tissue turnover plays a prominent role in tumour growth and metastasis. We followed serum levels of seven connective tissue parameters in 37 patients with colorectal cancer metastatic to the liver prior to and during chemotherapy. Serum samples with episodes of tumour control (n=112) showed an increase of matrix metalloproteinase-2 (MMP-2) (P⩽0.01) and a decrease of tissue inhibitor of MMPs (TIMP-1) levels (P⩽0.01), while serum samples with episodes of tumour progression displayed the reverse pattern (P⩽0.01 and P⩽0.05, resp.). The ratio of circulating MMP-2/TIMP-1 was also significantly higher in episodes of tumour control vs tumour progression and prior to treatment (P⩽0.0001). We conclude that serum MMP-2 appears to reflect tumour resorption, while serum TIMP-1 may mirror tumour expansion. Nature Publishing Group 2003-04-22 2003-04-15 /pmc/articles/PMC2747566/ /pubmed/12698191 http://dx.doi.org/10.1038/sj.bjc.6600832 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular and Cellular Pathology
Hanke, B
Wein, A
Martus, P
Riedel, C
Voelker, M
Hahn, E G
Schuppan, D
Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
title Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
title_full Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
title_fullStr Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
title_full_unstemmed Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
title_short Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
title_sort serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
topic Molecular and Cellular Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747566/
https://www.ncbi.nlm.nih.gov/pubmed/12698191
http://dx.doi.org/10.1038/sj.bjc.6600832
work_keys_str_mv AT hankeb serummarkersofmatrixturnoveraspredictorsfortheevolutionofcolorectalcancermetastasisunderchemotherapy
AT weina serummarkersofmatrixturnoveraspredictorsfortheevolutionofcolorectalcancermetastasisunderchemotherapy
AT martusp serummarkersofmatrixturnoveraspredictorsfortheevolutionofcolorectalcancermetastasisunderchemotherapy
AT riedelc serummarkersofmatrixturnoveraspredictorsfortheevolutionofcolorectalcancermetastasisunderchemotherapy
AT voelkerm serummarkersofmatrixturnoveraspredictorsfortheevolutionofcolorectalcancermetastasisunderchemotherapy
AT hahneg serummarkersofmatrixturnoveraspredictorsfortheevolutionofcolorectalcancermetastasisunderchemotherapy
AT schuppand serummarkersofmatrixturnoveraspredictorsfortheevolutionofcolorectalcancermetastasisunderchemotherapy